Transcriptional control of COX-2 via C/EBPβ

被引:62
|
作者
Wu, KK
Liou, JY
Cieslik, K
机构
[1] Univ Texas, Hlth Sci Ctr, Vasc Biol Res Ctr, Inst Mol Med, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Div Hematol, Houston, TX 77030 USA
关键词
aspirin; C/EBP; COX-2; inflammation; NF-kappa B;
D O I
10.1161/01.ATV.0000157899.35660.61
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cyclooxygenase-2 (COX-2) is a highly inducible enzyme exerting diverse actions on cell functions, including proliferation, migration, and DNA damage. Enhanced COX-2 expression may be protective, but excessive expression may be harmful, causing inflammation, atheromatous plaque instability, and intimal hyperplasia. COX-2 transcriptional activation by proinflammatory mediators has been extensively characterized. In this review, the role of C/EBP in regulating COX- 2 transcription is highlighted. Recent advances in control of COX- 2 transcription by aspirin and salicylate and by a cell cycle - dependent endogenous mechanism are described. The recent progress sheds light on the pathophysiological mechanisms of COX- 2 and new transcription-based strategy for controlling COX- 2 overexpression and COX- 2 - mediated cardiovascular diseases.
引用
收藏
页码:679 / 685
页数:7
相关论文
共 50 条
  • [1] Dysregulated post-transcriptional control of COX-2 gene expression in cancer
    Dixon, DA
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 635 - 646
  • [2] COX-2 in liver fibrosis
    Hu Yang
    Yang Xuefeng
    Wu Shandong
    Xiao Jianhua
    CLINICA CHIMICA ACTA, 2020, 506 : 196 - 203
  • [3] Alternate COX-2 transcripts are differentially regulated: Implications for post-transcriptional control
    Newton, R
    Seybold, J
    Liu, SF
    Barnes, PJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (01) : 85 - 89
  • [4] THE DEVELOPMENT OF COX-1 AND COX-2 INHIBITORS: A REVIEW
    Vishwakarma, Rahul Kumar
    Negi, D. S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (08): : 3544 - 3555
  • [5] COX-2 and atherosclerosis
    Cipollone, Francesco
    Fazia, Maria Luigia
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 : S26 - S36
  • [6] PC-SPES down-regulates COX-2 via inhibition of NF-κB and C/EBPβ in non-small cell lung cancer cells
    Ikezoe, Takayuki
    Yang, Yang
    Saitoh, Takayuki
    Heber, David
    McKenna, Robert
    Taguchi, Hirokuni
    Koeffler, H. Phillip
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (02) : 453 - 461
  • [7] Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer
    Yu, Tingting
    Lao, Xingzhen
    Zheng, Heng
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (15) : 1230 - 1243
  • [8] DPPC regulates COX-2 expression in monocytes via phosphorylation of CREB
    Morris, R. H. K.
    Tonks, A. J.
    Jones, K. P.
    Ahluwalia, M. K.
    Thomas, A. W.
    Tonks, A.
    Jackson, S. K.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 370 (01) : 174 - 178
  • [9] COX-2 and prostaglandins in atherosclerosis
    Cipollone, F
    LUPUS, 2005, 14 (09) : 756 - 759
  • [10] COX-2 in Radiotherapy: A Potential Target for Radioprotection and Radiosensitization
    Cheki, Mohsen
    Yahyapour, Rasoul
    Farhood, Bagher
    Rezaeyan, Abolhassan
    Shabeeb, Dheyauldeen
    Amini, Peyman
    Rezapoor, Saeed
    Najafi, Masoud
    CURRENT MOLECULAR PHARMACOLOGY, 2018, 11 (03) : 173 - 183